Clinical Study
Higher Ratio of Abdominal Subcutaneous to Visceral Adipose Tissue Related with Preservation of Islet β-Cell Function in Healthy Individuals
Table 2
Correlations coefficients of SAT, VAT, and SVR with glucose metabolism.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
; ; . ASAT: subcutaneous adipose tissue; VAT: visceral adipose tissue; SVR: the ratio of SAT to VAT; FPG: fasting plasma glucose; PG30min: 30 min plasma glucose during oral glucose tolerance (OGTT); PG120min: 120 min plasma glucose during OGTT; HOMA-IR: homeostasis assessment insulin resistance; HOMA-B: HOMA β-cell function; Matsuda index was calculated as 10,000/([(FPG × fasting plasma insulin) × (mean glucose during OGTT × mean insulin during OGTT)]). Basal DI: basal disposition index (DI) was calculated as HOMA-B/HOMA-IR; I0–30/G0–30 was calculated as [(30 min insulin (INS) + FINS) × 30/2]/[(30 min plasma glucose (PG) + FPG) × 18 × 30/2]; early-phase DI was calculated as I0–30/G0–30 × Matsuda index. I30–120/G30–120 was calculated as [(30 min INS + 120 min INS) × 90/2]/[(30 min PG + 120 min PG) × 18 × 90/2]; late-phase DI was calculated as I30–120/G30–120 × Matsuda index. |